Rob is a Managing Partner of Elm Street Ventures, a New Haven based seed and early stage venture capital fund that he founded in 2006, working closely with the Yale Investment Office and with Yale’s Office of Cooperative Research (OCR, the technology transfer office). Since inception, ESV has invested in 25 companies, of which 15 have licensed Yale technology. Rob serves as Chairman of P2 Science and is Elm Street’s observer on the board of Halda Therapeutics. Rob previously served as a board member of AxioMx, SeeClickFix, ShareGrove, and Retail Optimization Inc., and as an observer on the boards of Affomix Corporation, Arvinas, Device42, and Metagenomix. Mr. Bettigole has a BS in Engineering and Applied Science from Yale University and an MPPM from the Yale School of Management, where he has served as an Entrepreneur-in-Residence and as an Executive Fellow. He is a Licensed Professional Engineer and holds several U.S. and foreign patents. Mr. Bettigole served on the Operating Board of the Yale Entrepreneurial Institute from 2007 to 2017, and serves on the Investment Committee of the College Street Innovation Fund (formerly the YEI Innovation Fund), which is managed by Elm Street Ventures.